Parallel Advisors
VBIV icon

Parallel Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Parallel Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed – – 3342
2021
Q4 		$0 Buy
+3
New +$253 ﹤0.01% 3344

Other funds holding VBIV

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Parallel Advisors's VBIV Position: Q1 2022 in Review

Parallel Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2022, closing a stake of 3 shares.

Parallel Advisors first reported a position in VBIV in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 131 funds tracked by Wall St. Rank hold VBIV as of Q1 2022.

  • Parallel Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2022 after selling out during the quarter.
  • Parallel Advisors sold 3 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2022.
  • Parallel Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2021 and held it in 1 quarter.
  • Parallel Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $0 in Q4 2021.
  • 131 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.